Article 1 of Regulation (EU) No 823/2012 is amended as follows:
(1)
Point (2) is replaced by the following:
‘(2)
31 October 2016, as regards the active substances: deltamethrin (entry 40), 2,4-DB (entry 47), beta-cyfluthrin (entry 48), iprodione (entry 50), maleic hydrazide (entry 52), flurtamone (entry 64), flufenacet (entry 65), iodosulfuron (entry 66), dimethenamid-P (entry 67), picoxystrobin (entry 68), fosthiazate (entry 69), silthiofam (entry 70) and Coniothyrium minitans Strain CON/M/91-08 (DSM 9660) (entry 71);’.
(2)
The following point (5) is added:
‘(5)
30 April 2014, as regards the active substance: cyfluthrin (entry 49).’